Legal Status of Peptides in Canada (2026)
Research peptides are legal to purchase in Canada for scientific and in-vitro research use. The Food and Drugs Act (R.S.C., 1985, c. F-27) and the Controlled Drugs and Substances Act (CDSA) together define which compounds require prescription authorisation or scheduling. Research peptides such as BPC-157, TB-500, CJC-1295, Ipamorelin, GHK-Cu, Glutathione, and NAD+ are not listed on CDSA schedules and are not Prescription Drug List (PDL) entries when sold for research use.
Health Canada regulates products marketed as drugs or natural health products. ORYN's research-use-only positioning — no therapeutic claims, no dosing guidance, research-only labelling — keeps the products outside that framework.
Health Canada Compliance and CBSA Clearance
The Canada Border Services Agency (CBSA) handles import clearance. Research peptides dispatched from the EU with proper research-use labelling, a Certificate of Analysis, and a commercial invoice clearing the contents as "research chemicals — not for human consumption" pass through CBSA routinely.
Compliance points: - ORYN ships via DHL Express International with full customs pre-clearance - Every pen and carton clearly labelled "for research purposes only" - GMP manufacturing + independent HPLC purity verification (>99%) - COA from an accredited laboratory included in every shipment
AVAILABLE PEPTIDE PENS
Delivery to Canada — DHL Express duty-paid
ORYN delivers to all Canadian provinces in 5–8 business days via DHL Express International. Toronto, Vancouver, Montreal, Calgary, Ottawa, Edmonton, Winnipeg, and Quebec City receive orders in 5–6 business days; Yukon, Northwest Territories, and Nunavut add 2–3 days.
Delivery details: - Duty-paid DHL Express International (you pay nothing at the door) - Cold-chain insulated packaging - Discreet outer packaging with no product descriptors - COA and research-use declaration enclosed